Daniel K. Spiegelman, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 4,606 shares at $93.32 ($430K) on 2017-03-06, disclosed to the SEC on 2017-03-08.
Seasonal sale ($430k) by EVP, Chief Financial Officer — this insider has traded BMRN in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.32 | 2,303 | $215K | 50.0% |
| 2 | $93.32 | 2,303 | $215K | 50.0% |
| Total | $93.32 avg | 4,606 | $430K | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |